Pricing Log in Create free account

Pfizer Inc. (PFE) vs Sanofi (SNY)

Pfizer Inc. and Sanofi are both Drug Manufacturers General companies. Pfizer Inc. is the larger, with a market value of $170.3B against $111.8B — 1.5× the size. Sanofi trades at the lower P/E: 23.2× against 42.2×. Sanofi grew revenue faster over the last twelve months: 26.3% against 1.34%. Sanofi has the higher net margin (8.27% vs 6.34%) and the higher return on invested capital (7.05% vs 6.19%). Both pay a dividend; Pfizer Inc. yields more (7.18% vs 5.18%). Across the 23 metrics below, Sanofi leads on 16 and Pfizer Inc. on 7.

Valuation

Metric PFE SNY Drug Manufacturers General median
P/E 42.17 23.17 26.57
P/S 2.68 1.90 3.49
P/B 1.91 1.39 5.20
Price to free cash flow 15.54 6.71 21.34
EV/EBITDA 10.88 11.40 14.80
EV/Sales 3.44 2.13 4.09
Earnings yield 2.37% 4.32% 2.40%
Free cash flow yield 6.43% 14.90% 4.43%

Profitability

Metric PFE SNY Drug Manufacturers General median
Gross margin 73.38% 73.44% 73.01%
Operating margin 21.44% 18.73% 18.34%
Net margin 6.34% 8.27% 7.31%
Free cash flow margin 18.52% 40.26% 18.52%
Return on equity 4.42% 0.00% 5.80%
Return on assets 1.95% 3.24% 2.28%
Return on invested capital 6.19% 7.05% 6.26%

Growth

Metric PFE SNY Drug Manufacturers General median
Revenue growth (TTM) 1.34% 26.32% 6.72%
EPS growth (last fiscal year) (3.55%) 45.97% 21.81%
Revenue growth, 5-year CAGR 8.48% 4.37% 4.75%
Net income growth, 5-year CAGR (3.23%) (8.87%) 0.00%

Health

Metric PFE SNY Drug Manufacturers General median
Debt to equity 0.70 0.25 0.63
Current ratio 1.42 1.12 1.39
Net debt to EBITDA 2.46 0.76 1.15

Dividend

Metric PFE SNY Drug Manufacturers General median
Dividend yield 7.18% 5.18% 2.31%
Payout ratio 3.05 1.20 0.59

Size

Metric PFE SNY Drug Manufacturers General median
Market cap 170.31b 111.81b 131.21b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack